- Home
- CDNA vs DNUT Comparison
CDNA vs DNUT Comparison
Compare CDNA & DNUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- DNUT
- Stock Information
- Founded
- CDNA 1998
- DNUT 1937
- Country
- CDNA United States
- DNUT United States
- Employees
- CDNA N/A
- DNUT N/A
- Industry
- CDNA Medical Specialities
- DNUT Food Chains
- Sector
- CDNA Health Care
- DNUT Consumer Staples
- Exchange
- CDNA Nasdaq
- DNUT Nasdaq
- Market Cap
- CDNA 844.7M
- DNUT 739.0M
- IPO Year
- CDNA 2014
- DNUT 2021
- Fundamental
- Price
- CDNA $16.99
- DNUT $2.89
- Analyst Decision
- CDNA Buy
- DNUT Buy
- Analyst Count
- CDNA 6
- DNUT 8
- Target Price
- CDNA $30.33
- DNUT $10.23
- AVG Volume (30 Days)
- CDNA 1.4M
- DNUT 7.2M
- Earning Date
- CDNA 04-30-2025
- DNUT 05-08-2025
- Dividend Yield
- CDNA N/A
- DNUT 4.84%
- EPS Growth
- CDNA N/A
- DNUT N/A
- EPS
- CDNA 1.07
- DNUT N/A
- Revenue
- CDNA $346,421,000.00
- DNUT $1,597,883,000.00
- Revenue This Year
- CDNA $13.38
- DNUT N/A
- Revenue Next Year
- CDNA $15.33
- DNUT $3.61
- P/E Ratio
- CDNA $15.81
- DNUT N/A
- Revenue Growth
- CDNA 25.92
- DNUT N/A
- 52 Week Low
- CDNA $12.90
- DNUT $2.58
- 52 Week High
- CDNA $34.84
- DNUT $12.68
- Technical
- Relative Strength Index (RSI)
- CDNA 49.78
- DNUT 31.79
- Support Level
- CDNA $16.57
- DNUT $2.85
- Resistance Level
- CDNA $18.02
- DNUT $3.08
- Average True Range (ATR)
- CDNA 0.77
- DNUT 0.16
- MACD
- CDNA 0.14
- DNUT 0.03
- Stochastic Oscillator
- CDNA 59.45
- DNUT 17.65
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About DNUT Krispy Kreme Inc.
Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.